Contrasting Guided Therapeutics (OTCMKTS:GTHP) & Micron Solutions (OTCMKTS:MICR)

Institutional & Insider Ownership

9.7% of Guided Therapeutics shares are owned by institutional investors. 26.1% of Micron Solutions shares are owned by company insiders. Comparatively, 66.8% of Guided Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Risk and Volatility

Micron Solutions has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Comparatively, Guided Therapeutics has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500.

Profitability

This table compares Micron Solutions and Guided Therapeutics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Micron Solutions	N/A	N/A	N/A
Guided Therapeutics	N/A	N/A	-151.93%

Valuation and Earnings

This table compares Micron Solutions and Guided Therapeutics”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Micron Solutions	$22.57 million	0.00	-$1.29 million	($0.43)	N/A
Guided Therapeutics	$100,000.00	83.70	-$3.49 million	($0.03)	-4.27

Micron Solutions has higher revenue and earnings than Guided Therapeutics. Guided Therapeutics is trading at a lower price-to-earnings ratio than Micron Solutions, indicating that it is currently the more affordable of the two stocks.

About Micron Solutions

Micron Solutions, Inc. operates as a contract manufacturer for the medical device, defense, and life sciences markets. It offers precision machining, thermoplastic injection molding, mold making products; sensors; orthopedic implants and devices; and diagnostic test kits. The company provides solutions for medical, orthopedics, consumer, and automotive industries. Micron Solutions, Inc. was founded in 1978 and is based in Fitchburg, Massachusetts.

About Guided Therapeutics

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.